April 2017 - ITPC MENA

Apr 5, 2017

Access to medicines amendment of the WTO TRIPS Agreement– hype or hope?

Advocacy, ARV, HCV, Hepatitis, HIV, Intellectual Proprety, TB 13 Views

By: Ellen ‘t Hoen, Global Health Unit Department of Health Sciences, UMCG Groningen, e.f.m.t.hoen@umcg.nl On 30 January the World Trade Organization (WTO) announced the first ever amendment to the TRIPS Agreement under the headline

Apr 5, 2017

The HepC Pill Bill

Advocacy, ARV, Guidelines, HCV, Hepatitis, Sofosbuvir 15 Views

Source : hepCoalition The HepC Pill Bill-An insight into the availability, pricing and accessibility of HCV treatment Introduction to Direct Acting Antivirals Hepatitis C treatment has remarkably evolved over the years. The previously